A Nasdaq-listed company has made another move recently. Cypherpunk Technologies increased its holdings of ZEC again at the end of the year, purchasing approximately 56,000 Zcash, spending nearly $29 million.
In total, they now hold about 290,000 ZEC, accounting for 1.76% of the total Zcash circulation. The company previously announced its goal to eventually hold 5% of the circulating supply, and this recent increase brings them closer to that target.
Interestingly, the average purchase price was about $514 per coin. This move clearly isn't about short-term speculation but rather a genuine long-term asset allocation of ZEC. The company's investment lead, Will McEvoy, also confirmed this—he stated that the company is steadily executing its accumulation plan and won't change its stance due to price fluctuations.
There's an even more interesting story behind this. Cypherpunk was originally a biotech company called Leap Therapeutics. By 2025, the company shifted gears and rebranded itself as a digital asset firm focused on privacy-related encrypted assets. This major transformation was supported by Winklevoss Capital, indicating their strong confidence in this direction. It seems that as privacy becomes a more prominent public issue, more institutional investors are starting to adjust their asset allocation strategies.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
9 Likes
Reward
9
9
Repost
Share
Comment
0/400
AirdropATM
· 01-05 17:54
Really impressive, transitioning from biotech to the privacy coin sector—this move is truly bold.
View OriginalReply0
notSatoshi1971
· 01-05 11:04
Wow, switching from biotech to privacy encryption—this guy really has guts.
ZEC is really being targeted by institutions this time; a 5% circulating supply isn't a joke.
Wait, did you really buy 290,000 coins for an average of $514 each? Is this a long-term bullish view or just betting on a privacy narrative rebound?
The endorsement from Winklevoss is just outrageous; it feels like the privacy sector is about to explode.
Just listening to their unwavering promises is enough; let's see if they can really stick to it later.
This rhythm is a bit like Grayscale's strategy of accumulating BTC back in the day.
But I still want to see if ZEC can break $1,000; right now, the price is a bit awkward.
View OriginalReply0
大元亨通
· 01-03 12:51
View OriginalReply0
BottomMisser
· 01-03 07:50
Biotech companies rushing to buy privacy coins, this turnaround is too outrageous, but I like it.
View OriginalReply0
PonziWhisperer
· 01-03 07:50
Biotech companies turning to privacy coins is indeed a big move, and the endorsement from Winklevoss also says something.
View OriginalReply0
potentially_notable
· 01-03 07:48
Another biotech company comes to hoard coins, this plot is really incredible.
View OriginalReply0
GhostWalletSleuth
· 01-03 07:38
Really, an institution is accumulating ZEC. Transitioning from biotech directly to privacy assets, this move is even more aggressive than my portfolio.
View OriginalReply0
DancingCandles
· 01-03 07:27
Biotech shifts to the crypto privacy track, this move is incredible, even Winklevoss is endorsing it, a 5% target doesn't seem like a dream anymore.
View OriginalReply0
SelfCustodyIssues
· 01-03 07:25
This swing in direction is a bit significant, jumping straight from biotech to privacy coins. With Winklevoss betting on it, it really seems like they're not just playing around.
A Nasdaq-listed company has made another move recently. Cypherpunk Technologies increased its holdings of ZEC again at the end of the year, purchasing approximately 56,000 Zcash, spending nearly $29 million.
In total, they now hold about 290,000 ZEC, accounting for 1.76% of the total Zcash circulation. The company previously announced its goal to eventually hold 5% of the circulating supply, and this recent increase brings them closer to that target.
Interestingly, the average purchase price was about $514 per coin. This move clearly isn't about short-term speculation but rather a genuine long-term asset allocation of ZEC. The company's investment lead, Will McEvoy, also confirmed this—he stated that the company is steadily executing its accumulation plan and won't change its stance due to price fluctuations.
There's an even more interesting story behind this. Cypherpunk was originally a biotech company called Leap Therapeutics. By 2025, the company shifted gears and rebranded itself as a digital asset firm focused on privacy-related encrypted assets. This major transformation was supported by Winklevoss Capital, indicating their strong confidence in this direction. It seems that as privacy becomes a more prominent public issue, more institutional investors are starting to adjust their asset allocation strategies.